ORIGINAL ARTICLE

Primary biliary cirrhosis in female subjects with sicca-associated antibodies

Authors

Kunio Takada¹, Kimihiro Suzuki¹, Mitsuyo Matsumoto¹, Makoto Okada¹, Takashi Nakanishi¹, Hideyuki Horikoshi¹, Tomoaki Higuchi¹ and Fumitaka Ohsuzu¹

1. Department of Internal Medicine, Division of Rheumatology, National Defense Medical College, 3-2 Namiki, Tokorozawa 359-8513, Japan

Received:

02 July 2007

Accepted:

20 August 2007

Full Text

Download (PDF) （member's only）

Abstract

The aim of this study is to clarify the time course of primary biliary cirrhosis (PBC) in subjects possessing anticentromere antibodies (ACA), anti-Ro, and/or anti-La antibodies, and who used alkaline phosphatase (ALP) as a serological marker for PBC. Female subjects (n = 165), who had at least one of ACA, anti-Ro, and/or anti-La, were enrolled in this study. Groups A (ACA alone, n = 44), B (anti-Ro alone, n = 54), E (anti-Ro and anti-La, n = 52), and DFG (ACA with anti-Ro and/or anti-La, n = 14) were analyzed. Healthy females (n = 65) were used as a control. The frequencies of the PBC in groups A (13.6%) and DFG (14.3%) were higher than those in groups B (1.9%) and E (0.0%). The ALP levels increased with age in groups A and DFG and slightly increased with age in groups B and C, and the control group. After correcting for age by analysis of covariance, a comparison of ALP levels among the groups not having anti-M2 was as follows: group A ≒ group DFG > group B ≒ group E ≒ the control group. The subjects with ACA might thus have PBC more frequently than either those with anti-Ro and/or anti-La, or the control subjects.

Key words

Alkaline phosphatase - Anticentromere antibodies - Anti-La antibodies - Anti-Ro antibodies - Primary biliary cirrhosis